BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28977801)

  • 1. MiR-26a Mediates Ultraviolet B-Induced Apoptosis by Targeting Histone Methyltransferase EZH2 Depending on Myc Expression.
    Zhang T; Qian H; Hu C; Lu H; Li JB; Wu YF; Li W
    Cell Physiol Biochem; 2017; 43(3):1188-1197. PubMed ID: 28977801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma.
    Zhang X; Zhang X; Wang T; Wang L; Tan Z; Wei W; Yan B; Zhao J; Wu K; Yang A; Zhang R; Jia L
    Cancer Lett; 2018 Jul; 426():98-108. PubMed ID: 29653269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-340/iASPP axis affects UVB-mediated retinal pigment epithelium (RPE) cell damage.
    Yan J; Qin Y; Yu J; Peng Q; Chen X
    J Photochem Photobiol B; 2018 Sep; 186():9-16. PubMed ID: 29982095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mir-382 Promotes Differentiation of Rat Liver Progenitor Cell WB-F344 by Targeting Ezh2.
    Zheng Y; Zhou J; Li X; Xu G; Jin M; Shen R; Su R; Zhan S; Ding B; Jia M; Cui Y; Yu X
    Cell Physiol Biochem; 2018; 48(6):2389-2398. PubMed ID: 30121666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
    Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
    Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.
    Sander S; Bullinger L; Klapproth K; Fiedler K; Kestler HA; Barth TF; Möller P; Stilgenbauer S; Pollack JR; Wirth T
    Blood; 2008 Nov; 112(10):4202-12. PubMed ID: 18713946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Salomo K; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2249-61. PubMed ID: 27562865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
    Alzrigat M; Párraga AA; Agarwal P; Zureigat H; Österborg A; Nahi H; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
    Oncotarget; 2017 Feb; 8(6):10213-10224. PubMed ID: 28052011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-1246 releases RTKN2-dependent resistance to UVB-induced apoptosis in HaCaT cells.
    Li W; Wu YF; Xu RH; Lu H; Hu C; Qian H
    Mol Cell Biochem; 2014 Sep; 394(1-2):299-306. PubMed ID: 24880483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine induces podocyte apoptosis by regulating miR-1929-5p expression through c-Myc, DNMT1 and EZH2.
    Xie L; Ma S; Ding N; Wang Y; Lu G; Xu L; Wang Q; Liu K; Jie Y; Zhang H; Yang A; Gao Y; Zhang H; Jiang Y
    Mol Oncol; 2021 Nov; 15(11):3203-3221. PubMed ID: 34057794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
    Jing X; Yang J; Jiang L; Chen J; Wang H
    Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.
    Zhang X; Zhao X; Fiskus W; Lin J; Lwin T; Rao R; Zhang Y; Chan JC; Fu K; Marquez VE; Chen-Kiang S; Moscinski LC; Seto E; Dalton WS; Wright KL; Sotomayor E; Bhalla K; Tao J
    Cancer Cell; 2012 Oct; 22(4):506-523. PubMed ID: 23079660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LukS-PV-Regulated MicroRNA-125a-3p Promotes THP-1 Macrophages Differentiation and Apoptosis by Down-Regulating NF1 and Bcl-2.
    Sun XX; Zhang SS; Dai CY; Peng J; Pan Q; Xu LF; Ma XL
    Cell Physiol Biochem; 2017; 44(3):1093-1105. PubMed ID: 29179212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-26a protects type II alveolar epithelial cells against mitochondrial apoptosis.
    Xu BY; Li YL; Luan B; Zhang YL; Jia TM; Qiao JY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):486-491. PubMed ID: 29424907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma.
    Wu C; Ruan T; Liu W; Zhu X; Pan J; Lu W; Yan C; Tao K; Zhang W; Zhang C
    Curr Pharm Des; 2018; 24(5):564-575. PubMed ID: 28322158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis.
    Wong CF; Tellam RL
    J Biol Chem; 2008 Apr; 283(15):9836-43. PubMed ID: 18281287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer.
    Sun J; Cai X; Yung MM; Zhou W; Li J; Zhang Y; Li Z; Liu SS; Cheung ANY; Ngan HYS; Li Y; Dai Z; Kai Y; Tzatsos A; Peng W; Chan DW; Zhu W
    Oncogene; 2019 Jan; 38(4):564-580. PubMed ID: 30166592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.
    Zhang B; Liu XX; He JR; Zhou CX; Guo M; He M; Li MF; Chen GQ; Zhao Q
    Carcinogenesis; 2011 Jan; 32(1):2-9. PubMed ID: 20952513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression.
    Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
    Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.